Abstract
THE excitatory amino acid, L-glutamate, acting through its N-methyl-D-aspartate (NMD A) receptor, may contribute to neuronal death following cerebral vascular occlusion1–3. In support of this hypothesis, NMDA receptor antagonists reduce the volume of infarction produced by occlusion of the middle cerebral artery in vivo4,5 and attenuate Ca2+ influx and neuronal death elicited by L-glutamate or NMDA in vitro3,6. A complementary DNA coding for a major component of the NMDA receptor channel complex, a single protein of Mr 105.5K (NMDA-R1), has been isolated from rat brain7. Here we demonstrate that inhibition of the synthesis of NMDA-R1 by treatment with antisense oligodeoxynucleotides selectively reduces the expression of NMDA receptors, prevents the neurotoxicity elicited by NMDA in vitro and reduces the volume of the focal ischaemic infarction produced by occlusion of the middle cerebral artery in the rat.
Similar content being viewed by others
References
Meldrum, B. S. Clin. Sci. 68, 113–122 (1985).
Rothman, S. & Olney, J. W. Ann. Neurol. 19, 105–111 (1986).
Choi, D. W. Neuron 1, 623–634 (1988).
Park, C. K., Nehls, D. G., Graham, D. I., Teasdale, G. M. & McCulloch, J. Ann. Neurol. 24, 543–551 (1988).
Takizawa, S., Hogan, M. & Hakim, A. M. J. cereb. Blood Flow Metab. 11, 786–793 (1991).
Michaels, R. L. & Rothman, S. M. J. Neurosci. 10, 283–292 (1990).
Moryoshi, K., Masu, M., Ishii, T., Shigemoto, R. & Nakanishi, S. Nature 354, 31–37 (1991).
Nakanishi, N., Axel, R. & Schneider, N. A. Proc. natn. Acad. Sci. U.S.A. 89, 8552–8556 (1992).
Burnashev, N. et al. Science 257, 1415–1417 (1992).
Buchhalter, J. R. & Dichter, M. A. in Neuromethods 23: Practical Cell Culture Techniques (eds Boulton, A., Baker, G. & Walz, W.) 241–268 (Humana, Clifton, NJ, 1992).
Ransom, R. W., Eng, W.-s., Burns, D., Gibson, R. E. & Solomon, H. F. Life Sci. 46, 1103–1110 (1990).
Wahlestedt, C., Merlo Plch, E., Koob, G. F., Yee, F. & Heilig, M. Science 259, 528–531 (1993).
Honore, T., Drejer, J., Nielsen, E. O. & Nielsen, M. Biochem. Pharmac. 38, 3207–3212 (1989).
Reis, D. J., Berger, S. B., Underwood, M. D. & Khayata, M. J. cereb. Blood Flow Metab. 11, 810–818 (1991).
Meldrum, B. & Garthwaite, J. Trends pharmac. Sci. 11, 379–387 (1990).
Gill, R., Andine, P., Hillered, L., Persson, L. & Hagberg, H. J. cereb. Blood Flow Metab. 12, 371–379 (1992).
Franklin, S. B., Elliott, K., Zhu, Y.-S., Wahlestedt, C. & Inturrisi, C. E. Molec. Brain Res. (in the press).
Murphy, D. E., Hutchison, A. J., Hurt, S. D., Williams, M. & Sills, M. A. Br. J. Pharmac. 95, 932–938 (1988).
Toulme, J.-J. in Antisense RNA and DNA (ed. Murray, J. A. H.) 175–194 (Wiley-Liss, New York, 1992).
Bottenstein, J. & Sato, G. Proc. natn. Acad. Sci. U.S.A. 76, 514–517 (1979).
Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates 2nd edn (Academic, San Diego, 1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wahlestedt, C., Golanov, E., Yamamoto, S. et al. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363, 260–263 (1993). https://doi.org/10.1038/363260a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/363260a0
- Springer Nature Limited
This article is cited by
-
Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS
Cellular and Molecular Neurobiology (2021)
-
Oligonucleotide therapies for disorders of the nervous system
Nature Biotechnology (2017)
-
Amphetamine manipulates monoamine oxidase-A level and behavior using theranostic aptamers of transcription factors AP-1/NF-kB
Journal of Biomedical Science (2016)
-
NR1 Knockdown Reveals CA1 Injuryduring a Developmental Period of High Seizure Susceptibility Despite Reduced Seizure Activity
NeuroMolecular Medicine (2007)
-
Cytomegalovirus infection inhibits the expression of N-methyl-d-aspartate receptors in the developing mouse hippocampus and primary neuronal cultures
Acta Neuropathologica (2005)